Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Mar;102(3):711–717. doi: 10.1111/j.1476-5381.1991.tb12238.x

Changes in neurotransmitter sensitivity in the mouse neocortical slice following propranolol and theophylline administration.

J Mally 1, J H Connick 1, T W Stone 1
PMCID: PMC1917954  PMID: 1364843

Abstract

1. The mouse neocortical slice has been used to examine the sensitivity of neurones to isoprenaline, 5-hydroxytryptamine (5-HT) and adenosine acutely and following chronic treatment of animals with propranolol or theophylline. 2. While having little effect alone, all three agonists enhanced the d.c. depolarizing potential produced by N-methyl-D-aspartate (NMDA). The effect of (-)-isoprenaline (0.2 microM) was shared by (+)-isoprenaline at the much higher concentration of 10 microM. 3. Superfusion of slices with theophylline or 8-phenyltheophylline blocked responses to adenosine with evidence of selectivity. A single injection of theophylline 24 h before slice preparation did not alter agonist sensitivity, but when administered daily at 100 mg kg-1 for 14 days, the xanthine caused a loss of sensitivity to adenosine and (-)-isoprenaline but not 5-HT. The lower dose of theophylline, 10 mg kg-1 daily, also led to a loss of adenosine responses but no change of sensitivity to the amines. 4. Following the 14 day treatment with theophylline at 100 mg kg-1 daily in two groups of mice, responses to adenosine recovered to control levels after 20 days. 5. Propranolol superfusion blocked responses to both isomers of isoprenaline and 5-HT but did not affect sensitivity to adenosine. 6. Chronic treatment with propranolol at 25 mg kg-1 daily for 14 days induced a loss of sensitivity to (-)-isoprenaline and 5-HT but not adenosine. A lower dose of 5 mg kg-1 daily caused no change in responses to adenosine or 5-HT, but yielded an increased sensitivity to (-)-isoprenaline.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
711

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarons R. D., Molinoff P. B. Changes in the density of beta adrenergic receptors in rat lymphocytes, heart and lung after chronic treatment with propranolol. J Pharmacol Exp Ther. 1982 May;221(2):439–443. [PubMed] [Google Scholar]
  2. Anthony M. Beta-blockers in migraine prophylaxis. Drugs. 1978 Apr;15(4):249–250. doi: 10.2165/00003495-197815040-00001. [DOI] [PubMed] [Google Scholar]
  3. Boulenger J. P., Patel J., Post R. M., Parma A. M., Marangos P. J. Chronic caffeine consumption increases the number of brain adenosine receptors. Life Sci. 1983 Mar 7;32(10):1135–1142. doi: 10.1016/0024-3205(83)90119-4. [DOI] [PubMed] [Google Scholar]
  4. Burton N. R., Smith D. A., Stone T. W. A quantitative pharmacological analysis of some excitatory amino acid receptors in the mouse neocortex in vitro. Br J Pharmacol. 1988 Mar;93(3):693–701. doi: 10.1111/j.1476-5381.1988.tb10328.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Burton N. R., Smith D. A., Stone T. W. The mouse neocortical slice: preparation and responses to excitatory amino acids. Comp Biochem Physiol C. 1987;88(1):47–55. doi: 10.1016/0742-8413(87)90045-4. [DOI] [PubMed] [Google Scholar]
  6. Chiou W. L., Lam G., Chen M. L., Lee M. G. Effect of arterial-venous plasma concentration differences on the determination of mean residence time of drugs in the body. Res Commun Chem Pathol Pharmacol. 1982 Jan;35(1):17–26. [PubMed] [Google Scholar]
  7. Choi O. H., Shamim M. T., Padgett W. L., Daly J. W. Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors. Life Sci. 1988;43(5):387–398. doi: 10.1016/0024-3205(88)90517-6. [DOI] [PubMed] [Google Scholar]
  8. Daly J. W., Bruns R. F., Snyder S. H. Adenosine receptors in the central nervous system: relationship to the central actions of methylxanthines. Life Sci. 1981 May 11;28(19):2083–2097. doi: 10.1016/0024-3205(81)90614-7. [DOI] [PubMed] [Google Scholar]
  9. Daval J. L., Deckert J., Weiss S. R., Post R. M., Marangos P. J. Upregulation of adenosine A1 receptors and forskolin binding sites following chronic treatment with caffeine or carbamazepine: a quantitative autoradiographic study. Epilepsia. 1989 Jan-Feb;30(1):26–33. doi: 10.1111/j.1528-1157.1989.tb05276.x. [DOI] [PubMed] [Google Scholar]
  10. De Freitas B., Schwartz G. Effects of caffeine in chronic psychiatric patients. Am J Psychiatry. 1979 Oct;136(10):1337–1338. doi: 10.1176/ajp.136.10.1337. [DOI] [PubMed] [Google Scholar]
  11. Fredholm B. B. Adenosine actions and adenosine receptors after 1 week treatment with caffeine. Acta Physiol Scand. 1982 Jun;115(2):283–286. doi: 10.1111/j.1748-1716.1982.tb07078.x. [DOI] [PubMed] [Google Scholar]
  12. Fredholm B. B., Hedqvist P., Vernet L. Effect of theophylline and other drugs on rabbit renal cyclic nucleotide phosphodiesterase, 5'-nucleotidase and adenosine deaminase. Biochem Pharmacol. 1978;27(24):2845–2850. doi: 10.1016/0006-2952(78)90199-5. [DOI] [PubMed] [Google Scholar]
  13. Fredholm B. B., Herrera-Marschitz M., Jonzon B., Lindström K., Ungerstedt U. On the mechanism by which methylxanthines enhance apomorphine-induced rotation behaviour in the rat. Pharmacol Biochem Behav. 1983 Sep;19(3):535–541. doi: 10.1016/0091-3057(83)90131-4. [DOI] [PubMed] [Google Scholar]
  14. Fredholm B. B., Jonzon B., Lindgren E. Changes in noradrenaline release and in beta receptor number in rat hippocampus following long-term treatment with theophylline or L-phenylisopropyladenosine. Acta Physiol Scand. 1984 Sep;122(1):55–59. doi: 10.1111/j.1748-1716.1984.tb07481.x. [DOI] [PubMed] [Google Scholar]
  15. Fredholm B. B., Lindgren E. Inhibition of soluble 5'-nucleotidase from rat brain by different xanthine derivatives. Biochem Pharmacol. 1983 Sep 15;32(18):2832–2834. doi: 10.1016/0006-2952(83)90103-x. [DOI] [PubMed] [Google Scholar]
  16. Furukawa C. T., Shapiro G. G., DuHamel T., Weimer L., Pierson W. E., Bierman C. W. Learning and behaviour problems associated with theophylline therapy. Lancet. 1984 Mar 17;1(8377):621–621. doi: 10.1016/s0140-6736(84)91010-9. [DOI] [PubMed] [Google Scholar]
  17. Glaubiger G., Lefkowitz R. J. Elevated beta-adrenergic receptor number after chronic propranolol treatment. Biochem Biophys Res Commun. 1977 Sep 23;78(2):720–725. doi: 10.1016/0006-291x(77)90238-8. [DOI] [PubMed] [Google Scholar]
  18. Goldberg M. R., Curatolo P. W., Tung C. S., Robertson D. Caffeine down-regulates beta adrenoreceptors in rat forebrain. Neurosci Lett. 1982 Jul 20;31(1):47–52. doi: 10.1016/0304-3940(82)90052-0. [DOI] [PubMed] [Google Scholar]
  19. Green R. M., Stiles G. L. Chronic caffeine ingestion sensitizes the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex. J Clin Invest. 1986 Jan;77(1):222–227. doi: 10.1172/JCI112280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Griffiths R. R., Bigelow G. E., Liebson I. A. Human coffee drinking: reinforcing and physical dependence producing effects of caffeine. J Pharmacol Exp Ther. 1986 Nov;239(2):416–425. [PubMed] [Google Scholar]
  21. Haas H. L., Greene R. W. Adenosine enhances afterhyperpolarization and accommodation in hippocampal pyramidal cells. Pflugers Arch. 1984 Nov;402(3):244–247. doi: 10.1007/BF00585506. [DOI] [PubMed] [Google Scholar]
  22. Haas H. L., Rose G. M. Noradrenaline blocks potassium conductance in rat dentate granule cells in vitro. Neurosci Lett. 1987 Jul 22;78(2):171–174. doi: 10.1016/0304-3940(87)90628-8. [DOI] [PubMed] [Google Scholar]
  23. Hallberg H. Blockade of central beta-adrenoceptors attenuates tremor induced by 5-hydroxytryptamine (5-HT)-receptor activation in rats. Acta Physiol Scand. 1987 Mar;129(3):421–428. doi: 10.1111/j.1748-1716.1987.tb08087.x. [DOI] [PubMed] [Google Scholar]
  24. Harrison N. L., Simmonds M. A. Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex. Br J Pharmacol. 1985 Feb;84(2):381–391. doi: 10.1111/j.1476-5381.1985.tb12922.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hawkins M., Dugich M. M., Porter N. M., Urbancic M., Radulovacki M. Effects of chronic administration of caffeine on adenosine A1 and A2 receptors in rat brain. Brain Res Bull. 1988 Sep;21(3):479–482. doi: 10.1016/0361-9230(88)90162-1. [DOI] [PubMed] [Google Scholar]
  26. Heiser J. F., Defrancisco D. The treatment of pathological panic states with propranolol. Am J Psychiatry. 1976 Dec;133(12):1389–1394. doi: 10.1176/ajp.133.12.1389. [DOI] [PubMed] [Google Scholar]
  27. Kuroda Y., Kakigi R., Shibasaki H. Treatment of essential tremor with arotinolol. Neurology. 1988 Apr;38(4):650–652. doi: 10.1212/wnl.38.4.650. [DOI] [PubMed] [Google Scholar]
  28. Linken A. Propranolol for L.S.D.-induced anxiety states. Lancet. 1971 Nov;2(7732):1039–1040. doi: 10.1016/s0140-6736(71)90360-6. [DOI] [PubMed] [Google Scholar]
  29. Madison D. V., Nicoll R. A. Actions of noradrenaline recorded intracellularly in rat hippocampal CA1 pyramidal neurones, in vitro. J Physiol. 1986 Mar;372:221–244. doi: 10.1113/jphysiol.1986.sp016006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Madsen S. M., Ribel U. Pharmacokinetics of theophylline and 3-methylxanthine in guinea pigs. II. Multiple dose administration. Acta Pharmacol Toxicol (Copenh) 1981 Jan;48(1):8–12. doi: 10.1111/j.1600-0773.1981.tb01580.x. [DOI] [PubMed] [Google Scholar]
  31. Mally J. Aminophylline and essential tremor. Lancet. 1989 Jul 29;2(8657):278–279. doi: 10.1016/s0140-6736(89)90464-9. [DOI] [PubMed] [Google Scholar]
  32. Marangos P. J., Boulenger J. P., Patel J. Effects of chronic caffeine on brain adenosine receptors: regional and ontogenetic studies. Life Sci. 1984 Feb 27;34(9):899–907. doi: 10.1016/0024-3205(84)90207-8. [DOI] [PubMed] [Google Scholar]
  33. Marshall K. C., Tsai W. H. Noradrenaline induces short and long duration potentiation of glutamate excitations of cultured Purkinje neurons. Can J Physiol Pharmacol. 1988 Jun;66(6):848–853. doi: 10.1139/y88-137. [DOI] [PubMed] [Google Scholar]
  34. Middlemiss D. N. Stereoselective blockade at [3H]5-HT binding sites and at the 5-HT autoreceptor by propranolol. Eur J Pharmacol. 1984 Jun 1;101(3-4):289–293. doi: 10.1016/0014-2999(84)90173-0. [DOI] [PubMed] [Google Scholar]
  35. Mori-Okamoto J., Tasuno J. Participation of cyclic adenosine monophosphate and beta-adrenergic receptors in the facilitatory effect of noradrenaline on the response of cultured cerebellar neurons to glutamate. Brain Res. 1989 Jun 19;490(1):64–72. doi: 10.1016/0006-8993(89)90431-9. [DOI] [PubMed] [Google Scholar]
  36. Murray T. F. Up-regulation of rat cortical adenosine receptors following chronic administration of theophylline. Eur J Pharmacol. 1982 Aug 13;82(1-2):113–114. doi: 10.1016/0014-2999(82)90563-5. [DOI] [PubMed] [Google Scholar]
  37. Phillis J. W. Evidence for an A2-like adenosine receptor on cerebral cortical neurons. J Pharm Pharmacol. 1982 Jul;34(7):453–454. doi: 10.1111/j.2042-7158.1982.tb04757.x. [DOI] [PubMed] [Google Scholar]
  38. Richards M. H. Efflux of 3H-5-hydroxytryptamine from rat hypothalamic slices by continuous electrical stimulation: frequency-dependent responses to serotonergic antagonists and 5-hydroxytryptamine. Naunyn Schmiedebergs Arch Pharmacol. 1985 Jun;329(4):359–366. doi: 10.1007/BF00496368. [DOI] [PubMed] [Google Scholar]
  39. Sanders R. C., Murray T. F. Chronic theophylline exposure increases agonist and antagonist binding to A1 adenosine receptors in rat brain. Neuropharmacology. 1988 Jul;27(7):757–760. doi: 10.1016/0028-3908(88)90086-x. [DOI] [PubMed] [Google Scholar]
  40. Sattin A., Rall T. W. The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices. Mol Pharmacol. 1970 Jan;6(1):13–23. [PubMed] [Google Scholar]
  41. Segal M. Intracellular analysis of a postsynaptic action of adenosine in the rat hippocampus. Eur J Pharmacol. 1982 Apr 23;79(3-4):193–199. doi: 10.1016/0014-2999(82)90625-2. [DOI] [PubMed] [Google Scholar]
  42. Smits J. M., Struyker-Boudier H. A. Propranolol in conscious spontaneously hypertensive rats. II. Disposition after subcutaneous and intracerebroventricular administration. Naunyn Schmiedebergs Arch Pharmacol. 1979 Oct;309(1):19–24. doi: 10.1007/BF00498752. [DOI] [PubMed] [Google Scholar]
  43. Snyder S. H., Katims J. J., Annau Z., Bruns R. F., Daly J. W. Adenosine receptors and behavioral actions of methylxanthines. Proc Natl Acad Sci U S A. 1981 May;78(5):3260–3264. doi: 10.1073/pnas.78.5.3260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Spealman R. D. Psychomotor stimulant effects of methylxanthines in squirrel monkeys: relation to adenosine antagonism. Psychopharmacology (Berl) 1988;95(1):19–24. doi: 10.1007/BF00212759. [DOI] [PubMed] [Google Scholar]
  45. Stone T. W., Burton N. R. NMDA receptors and ligands in the vertebrate CNS. Prog Neurobiol. 1988;30(4):333–368. doi: 10.1016/0301-0082(88)90027-5. [DOI] [PubMed] [Google Scholar]
  46. Stone T. W. Physiological roles for adenosine and adenosine 5'-triphosphate in the nervous system. Neuroscience. 1981;6(4):523–555. doi: 10.1016/0306-4522(81)90145-7. [DOI] [PubMed] [Google Scholar]
  47. Stone T. W. Purine receptors involved in the depression of neuronal firing in cerebral cortex. Brain Res. 1982 Sep 30;248(2):367–370. doi: 10.1016/0006-8993(82)90596-0. [DOI] [PubMed] [Google Scholar]
  48. Szot P., Sanders R. C., Murray T. F. Theophylline-induced upregulation of A1-adenosine receptors associated with reduced sensitivity to convulsants. Neuropharmacology. 1987 Aug;26(8):1173–1180. doi: 10.1016/0028-3908(87)90264-4. [DOI] [PubMed] [Google Scholar]
  49. Taylor E. A., Jefferson D., Carroll J. D., Turner P. Cerebrospinal fluid concentrations of propranolol, pindolol and atenolol in man: evidence for central actions of beta-adrenoceptor antagonists. Br J Clin Pharmacol. 1981 Oct;12(4):549–559. doi: 10.1111/j.1365-2125.1981.tb01264.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Terao N., Shen D. D. Effect of experimental renal failure on the disposition kinetics of l-propranolol in rats. J Pharmacol Exp Ther. 1983 Nov;227(2):295–301. [PubMed] [Google Scholar]
  51. Terao N., Shen D. D. Pharmacokinetics of l-propranolol during repetitive dosing in normal and uranyl nitrate-induced renal failure rats. J Pharmacokinet Biopharm. 1984 Oct;12(5):479–493. doi: 10.1007/BF01060127. [DOI] [PubMed] [Google Scholar]
  52. Trussell L. O., Jackson M. B. Adenosine-activated potassium conductance in cultured striatal neurons. Proc Natl Acad Sci U S A. 1985 Jul;82(14):4857–4861. doi: 10.1073/pnas.82.14.4857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Walle T., Walle U. K. Stereoselective oral bioavailability of (+/-)-propranolol in the dog. A GC-MS study using a stable isotope technique. Res Commun Chem Pathol Pharmacol. 1979 Mar;23(3):453–464. [PubMed] [Google Scholar]
  54. Watkins J. C., Evans R. H. Excitatory amino acid transmitters. Annu Rev Pharmacol Toxicol. 1981;21:165–204. doi: 10.1146/annurev.pa.21.040181.001121. [DOI] [PubMed] [Google Scholar]
  55. Weber R. B., Reinmuth O. M. The treatment of migraine with propranolol. Neurology. 1972 Apr;22(4):366–369. doi: 10.1212/wnl.22.4.366. [DOI] [PubMed] [Google Scholar]
  56. Weinstock M., Schechter Y. Antagonism by propranolol of the ganglion stimulant action of 5-hydroxytryptamine. Eur J Pharmacol. 1975 Jun-Jul;32(02):293–301. doi: 10.1016/0014-2999(75)90296-4. [DOI] [PubMed] [Google Scholar]
  57. Williams M. Purine receptors in mammalian tissues: pharmacology and functional significance. Annu Rev Pharmacol Toxicol. 1987;27:315–345. doi: 10.1146/annurev.pa.27.040187.001531. [DOI] [PubMed] [Google Scholar]
  58. Wohlberg C. J., Hackman J. C., Davidoff R. A. Epinephrine and norepinephrine modulate neuronal responses to excitatory amino acids and agonists in frog spinal cord. Synapse. 1987;1(2):202–207. doi: 10.1002/syn.890010208. [DOI] [PubMed] [Google Scholar]
  59. Wolfe B. B., Harden T. K., Sporn J. R., Molinoff P. B. Presynaptic modulation of beta adrenergic receptors in rat cerebral cortex after treatment with antidepressants. J Pharmacol Exp Ther. 1978 Nov;207(2):446–457. [PubMed] [Google Scholar]
  60. Wolfe B. B., Minneman K. P., Molinoff P. B. Selective increases in the density of cerebellar beta-1-adrenergic receptors. Brain Res. 1982 Feb 25;234(2):474–479. doi: 10.1016/0006-8993(82)90890-3. [DOI] [PubMed] [Google Scholar]
  61. Woolfrey S. G., Palin K. J., Davis S. S. The effect of Miglycol 812 oil on the oral absorption of propranolol in the rat. J Pharm Pharmacol. 1989 Aug;41(8):579–581. doi: 10.1111/j.2042-7158.1989.tb06534.x. [DOI] [PubMed] [Google Scholar]
  62. Young R. R., Growdon J. H., Shahani B. T. Beta-adrenergic mechanisms in action tremor. N Engl J Med. 1975 Nov 6;293(19):950–953. doi: 10.1056/NEJM197511062931902. [DOI] [PubMed] [Google Scholar]
  63. Zielke C. L., Zielke H. R. Chronic exposure to subcutaneously implanted methylxanthines. Differential elevation of A1-adenosine receptors in mouse cerebellar and cerebral cortical membranes. Biochem Pharmacol. 1987 Aug 1;36(15):2533–2538. doi: 10.1016/0006-2952(87)90527-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES